Challenges With Neoadjuvant Endocrine Therapy In Breast Cancer

Challenges With Neoadjuvant Endocrine Therapy in Breast Cancer

Targeted Oncology

Challenges With Patient Selection for Extended Adjuvant Endocrine Therapy in Breast Cancer

Targeted Oncology

Evaluating the Role of Neoadjuvant Endocrine Therapy in Breast Cancer

Targeted Oncology

Dr. Ellis on Neoadjuvant Endocrine Therapy for Breast Cancer

Dr. Holmes on Neoadjuvant Endocrine Therapy in Breast Cancer

Dr. Pegram on Challenges in Neoadjuvant Treatment for HER2-Positive Breast Cancer

Dr. Judy Boughey on Neoadjuvant Endocrine Therapy in Breast Cancer

Targeted Oncology

ALTERNATE: neoadjuvant endocrine treatment in ER+/HER2- breast cancer

Dr. Khong on the Benefit of Neoadjuvant Endocrine Therapy in ER+ Breast Cancers

Neoadjuvant Endocrine Therapy in Breast Cancer

Advanced Breast Cancer: Challenges in Pathways Development

The challenges of treatment sequencing in HR+ breast cancer patients

Neoadjuvant Therapy for HR+ Breast Cancer

Neoadjuvant hormonal treatment for luminal breast cancer: rationale, evidence and outcome

Endocrine therapy in premenopausal women with HR+ breast cancer

Neoadjuvant Therapy for HER2-positive Breast Cancer - Dr. Scott Christensen

Exploring Neoadjuvant Therapy for Breast Cancer: What You Need to Know

Yerbba – Breast Cancer

Utilizing neoadjuvant immunotherapies in patients with ER+, HER2- primary breast cancer

Management of challenging breast findings including assessment after neoadjuvant systemic therapy

Dr. Mamounas on Adjuvant Endocrine Therapy for Breast Cancer